Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	104.13	227.38	239.57	382.44	310.34
Short-Term Investments	196.58	360.64	-	-	-
Cash & Short-Term Investments	300.71	588.02	239.57	382.44	310.34
Cash Growth	-48.86%	145.45%	-37.36%	23.23%	102.44%
Accounts Receivable	24.55	0.95	1.05	0.15	0.07
Other Receivables	51.24	47.3	23.5	28.82	26.18
Receivables	75.79	48.24	24.54	28.98	26.25
Inventory	33.21	4.14	-	-	-
Prepaid Expenses	21.28	15.21	8.64	12.34	8.71
Restricted Cash	1.5	1.43	0.77	0.33	0.34
Other Current Assets	3.43	3.89	1.79	1.7	1.31
Total Current Assets	435.92	660.93	275.3	425.77	346.95
Property, Plant & Equipment	128.5	105.05	95.65	58.42	52.32
Other Intangible Assets	19.81	12.37	-	-	0.07
Long-Term Deferred Tax Assets	3.56	3.24	3.06	2.08	1.83
Other Long-Term Assets	1.28	1.13	1.36	4.01	4.4
Total Assets	589.07	782.73	375.38	490.27	405.56
Accounts Payable	3.08	1.97	0.1	0.53	0.43
Accrued Expenses	53.76	51.8	39.05	40.4	23.51
Current Portion of Leases	4.57	3	5.05	5.04	4.45
Other Current Liabilities	12.03	3.98	0.53	0.39	0.16
Total Current Liabilities	73.44	60.74	44.74	46.37	28.55
Long-Term Debt	270.2	244.6	170.9	125.9	47.02
Long-Term Leases	66.82	49.63	47.91	19.22	16.55
Other Long-Term Liabilities	0.48	0.43	0.36	0.12	0.13
Total Liabilities	410.94	355.4	263.91	191.6	92.24
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,570	1,556	1,019	1,008	843.11
Retained Earnings	-1,387	-1,099	-878.56	-670.18	-521.34
Comprehensive Income & Other	-5.24	-29.06	-28.87	-38.78	-8.45
Shareholders' Equity	178.13	427.33	111.47	298.67	313.32
Total Liabilities & Equity	589.07	782.73	375.38	490.27	405.56
Total Debt	341.59	297.23	223.87	150.16	68.01
Net Cash (Debt)	-40.88	290.79	15.7	232.28	242.32
Net Cash Growth	-	1752.19%	-93.24%	-4.15%	144.43%
Net Cash Per Share	-0.15	1.14	0.09	2.45	3.36
Filing Date Shares Outstanding	266.14	266.13	265.93	173.07	90.91
Total Common Shares Outstanding	266.14	266.12	174.1	173.07	90.91
Working Capital	362.48	600.19	230.57	379.41	318.4
Book Value Per Share	0.67	1.61	0.64	1.73	3.45
Tangible Book Value	158.32	414.95	111.47	298.67	313.26
Tangible Book Value Per Share	0.59	1.56	0.64	1.73	3.45
Machinery	65.12	50.42	38.37	35.98	38.92
Construction In Progress	27.08	19.64	12.54	13.19	2.44
Leasehold Improvements	15.76	14.12	12.73	11.69	14.9

Updated Mar 27, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q